MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • MDS Virtual Congress 2020

    Novel GNO1 mutation in monozygotic twins responsive to DBS

    B. Bulica (West Bloomfield, MI, USA)

    Objective: GNAO1 is located on chromosome 16q12.2 and encodes Gα0 subunit of the heterotrimeric guanine-binding protein necessary for neuronal signaling. It is thought that loss-of-function GNAO1…
  • MDS Virtual Congress 2020

    Phenotypic analysis of subjects with homozygous and compound heterozygous PANK2 mutations in a single extended pedigree from the Dominican Republic (DR) PKAN cohort

    F. Middleton, C. Muniz, I. Ojukwu, M. Santana Jimenez, P. Stoeter, R. Ericson, A. Espinoza, C. Bass, P. Roa, S. Baser (Santo Domingo, Dominican Republic)

    Objective: Whole exome sequencing and genotypic screening of homozygous and heterozygous PANK2 mutations in the Dominican Republic. Background: PKAN affects 1 in 1,000,000 people worldwide,…
  • MDS Virtual Congress 2020

    Mutation screening and clinical features analysis in patients with early-onset primary dystonia

    X.J Gu, J. Yang, L.Y Zhang, QQ. Wei, H.F Shang (Chengdu, China)

    Objective: In this context, it is important to reveal the mutation frequency of primary dystonia related genes using target dystonia related gene panel among a…
  • MDS Virtual Congress 2020

    Comprehensive Screening of Genetic, Genomic, Mitochondrial, and Microbiome Associations with Phenotypic Measures in the Dominican Republic PKAN Cohort

    C. Muniz, S. Baser, C. Bass, R. Ericson, A. Espinoza, I. Ojukwu, A. Brindle, M. Santana Jimenez, F. Middleton (Santo Domingo, Dominican Republic)

    Objective: Establish novel molecular predictors of phenotypic variation using screening of genomic, transcriptomic, mitochondrial, microbiome, and clinical features. Background: Pantothenate Kinase Associated Neurodegeneration (PKAN), also…
  • MDS Virtual Congress 2020

    Frequency and phenotypic spectrum of ANO3 dystonia: A single-center cohort study

    L.T Jiang, L.X Li, Y. Liu, X.L Zhang, Y.G Pan, L.J Jin (Shanghai, China)

    Objective: To further clarify the spectrum and frequency of ANO3 rare variants in Chinese populations with primary dystonia. Background: Dystonia is a movement disorder with…
  • MDS Virtual Congress 2020

    KMT2B-related dystonia (DYT28) and Klippel-Feil Syndrome: A new association?

    D. Portela, M. Correa, M. Gomes, G. Noleto, C. Costa, J. Lopes, L. de Oliveira (Teresina, Brazil)

    Objective: To report the association of lysine-specific histone-methyltransferase 2B gene (KMT2B)-related dystonia (DYT28) and Klippel-Feil Syndrome (KFS). Background: Dystonia is a hyperkinetic movement disorder characterized…
  • MDS Virtual Congress 2020

    A case of generalized early-onset dystonia with a novel low-penetrant THAP1 missense variant

    I. Keller Sarmiento, A. Fraint, L. Kinsley, S. Lubbe, N. Mencacci, T. Simuni, D. Krainc (Chicago, IL, USA)

    Objective: To present a new case with generalized dystonia carrying a novel heterozygous likely pathogenic THAP1 variant associated with reduced penetrance Background: Dystonia is a…
  • MDS Virtual Congress 2020

    Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome

    S. Weber, M. Zech, S. Boesch, J. Winkelmann (Kassel, Germany)

    Objective: To enrich the limited clinical and genetic data of an extremely rare recessive ataxia subtype. Background: Advances in NGS techniques led to an increase…
  • MDS Virtual Congress 2020

    Genetic testing in pediatric dystonia and influence of clinical factors on diagnostic yield

    T. Larsh, H. Fernandez, M. Aldosari (Cleveland, OH, USA)

    Objective: To identify the yield of genetic testing in suspected genetically determined pediatric dystonia. Identify differences in clinical factors among patients with confirmatory and non-confirmatory…
  • MDS Virtual Congress 2020

    Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

    T. Wirth, LL. Mariani, G. Bergant, M. Baulac, M.O Habert, N. Drouot, E. Ollivier, A. Hodžic, G.o Rudolf, P. Nitschke, G.a Rudolf, J. Chelly, C. Tranchant, M. Anheim, E. Roze (London, United Kingdom)

    Objective: To report two patients with early-onset dystonia-parkinsonism as a result of loss-of-function mutations in nuclear receptor subfamily 4 group A member 2 (NR4A2). Background:…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley